ICON plc - Ordinary Shares (ICLR): Price and Financial Metrics
ICLR Stock Price Chart More Charts
ICLR Price/Volume Stats
|Current price||$177.22||52-week high||$177.52|
|Prev. close||$173.69||52-week low||$127.58|
|Day high||$177.52||Avg. volume||201,833|
|50-day MA||$170.09||Dividend yield||N/A|
|200-day MA||$154.62||Market Cap||9.56B|
ICON plc - Ordinary Shares (ICLR) Company Bio
ICON Public Limited Company provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company was founded in 1990 and is based in Dublin, Ireland.
ICLR Price Forecast Based on DCF Valuation
|Current Price||DCF Fair Value Target:||Forecasted Gain:|
We started the process of determining a valid price forecast for Icon Plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Icon Plc ranked in the 26st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Icon Plc ended up being:
- The company's debt burden, as measured by earnings divided by interest payments, is 28; that's higher than 83.86% of US stocks in the Healthcare sector that have positive free cash flow.
- The business' balance sheet suggests that 4% of the company's capital is sourced from debt; this is greater than only 13.32% of the free cash flow producing stocks we're observing.
- ICLR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 55.65% of tickers in our DCF set.
|Terminal Growth Rate in Free Cash Flow||Return Relative to Current Share Price|